Found 0 matching trials
Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops
NAThe purpose of the study is to determine the effectiveness of rizatriptan f...
Location
Madigan Army Medical Center - Neurology Clinic
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
PHASE3To provide long term safety data for rizatriptan in children and adolescent...
Location
Multiple Locations
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
PHASE3The purpose of this study is to test the effectiveness of a marketed drug i...
Location
Multiple Locations
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
N/AChronic Migraine (CM), or 15 or more migraine headaches per month, is commo...
Location
Multiple Locations
Two Rizatriptan Prescribing Portions for Treatment of Migraine
PHASE4The primary objective of this study is to evaluate a clinical limit (CL) of...
Location
Brian Koffman, MD
Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine
PHASE3A phase III study, multicenter, double-blind, double-dummy, randomized, sin...
Location
Eurofarma Laboratorios S.A
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
PHASE2The purpose of this study is to investigate the efficacy and safety of an M...
Location
Multiple Locations
Maximizing Outcomes in Treating Acute Migraine
PHASE3AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam ...
Location
Clinical Research Site
MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
PHASE3A study to evaluate rizatriptan/MK0462 (5 and 10 mg) for the treatment of a...
Location
Multiple Locations
Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.
PHASE4Triptans are first choice drugs in the acute treatment of migraine and clus...
Location
IRCCS San Raffaele Pisana, Clinical Trial Center